The FDA laid out a proposed new regulatory plan to oversee potentially thousands of laboratory-developed medical tests that the agency contends can be prone to errors.
via WSJ.com: US Business http://ift.tt/1uMiPIJ
via WSJ.com: US Business http://ift.tt/1uMiPIJ
Nessun commento:
Posta un commento